Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?

Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia

(2019) Martin Adiels et al.   DIABETES OBESITY & METABOLISM

Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes

(2019) Jenny E. Kanter et al.   JOURNAL OF CLINICAL INVESTIGATION

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding

(2018) Allan D. Sniderman et al.   JOURNAL OF LIPID RESEARCH

Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII

(2015) Haibo Li et al.   CARDIOVASCULAR RESEARCH

Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia

(2010) Sandrine Caron et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

(2008) T. I. Pollin et al.   SCIENCE